Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SGMS1 | Q86VZ5 | 11/20 | 1.00 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.64 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9512082 | 0.81 | TBXA2R (0.76) | SGMS1TBXA2RTBXAS1ALDH1A1POLB | |
| SCHEMBL13401889 | 0.80 | KMT2A (0.67) | SGMS1ALDH1A1POLB | |
| SCHEMBL13401884 | 0.80 | ALDH1A1 (0.79) | SGMS1ALDH1A1 | |
| SCHEMBL9129394 | 0.80 | SGMS1 (0.74) | SGMS1ALDH1A1HTT | |
| SCHEMBL3915476 | 0.79 | PRMT1 (0.71) | SGMS1ALDH1A1POLB | |
| SCHEMBL23294744 | 0.79 | TBXA2R (0.73) | SGMS1TBXA2RTBXAS1ALDH1A1POLB | |
| Sulotroban SCHEMBL34187 | 0.78 | TBXA2R (1.00) | SGMS1TBXA2RTBXAS1ALDH1A1POLB | |
| SCHEMBL15145811 | 0.78 | POLB (0.74) | SGMS1ALDH1A1POLBHTT | |
| SCHEMBL9128396 | 0.78 | SGMS1 (0.91) | SGMS1TBXA2RTBXAS1ALDH1A1HTT | |
| Sulotroban SCHEMBL9585833 | 0.78 | TBXA2R (0.79) | SGMS1TBXA2RTBXAS1ALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118161616-A | Use of SMS1 and sphingomyelin synthetic pathway as therapeutic target for fever with thrombocytopenia syndrome | 中国人民解放军军事科学院军事医学研究院 | 2024-06-11 | — | — | CN | claimed |
| WO-2026100539-A1 | PHARMACEUTICAL COMPOSITION FOR PROMOTING MIGRATION OF SUBSTANCE TO CENTRAL NERVOUS SYSTEM | 小野薬品工業株式会社 | 2026-05-15 | — | — | WO | disclosed |